News

Partnership Between AbbVie and Chicago Cubs to Fight Cancer

Partnership Between AbbVie and Chicago Cubs to Fight Cancer

AbbVie Collaborates with Chicago Cubs for a Noble Cause

AbbVie, a global biopharmaceutical leader, has recently formed an exciting partnership with the Chicago Cubs to launch a groundbreaking campaign called 'Striking Out Cancer.' This campaign aims to increase awareness and support for individuals living with cancer while assisting non-profit organizations dedicated to battling this relentless disease.

Campaign Objectives and Donations Structure

As part of this collaboration, AbbVie is committing to contribute $233 for every strikeout made by a Cubs pitcher during the home games of the regular season for the year in question. This donation amount reflects a poignant statistic, with approximately 233 Americans diagnosed with cancer every hour, as reported by the American Cancer Society. This connection between sports and health creates a significant impact, turning each strikeout into a lifeline for those affected by cancer.

Voices Behind the Initiative

Tracie Haas, senior vice president of corporate affairs at AbbVie, expressed her enthusiasm for the partnership. She stated, "Every strikeout this Cubs season is more than just a number; it represents our continued commitment to support individuals battling cancer. Together with the Cubs, we intend to raise awareness and generate substantial contributions for cancer advocacy globally." This sentiment highlights the positive influence that sports can have beyond the field, aiming to make a meaningful difference in the lives of many.

Beneficiaries of the Campaign

The funds raised through this initiative will be directed to the Cubs Charities, which assists several not-for-profit organizations striving to enhance cancer research and support. Among the beneficiaries will be Conquer Cancer®, the ASCO Foundation, which actively accelerates breakthroughs in cancer treatments and empowers individuals globally in their fight against cancer.

AbbVie’s Commitment to Oncology

AbbVie’s dedication to oncology aligns with their broader mission to discover and develop transformative medications for various health challenges. With therapies tailored for leukemia, lymphoma, and other forms of cancer, AbbVie stands at the forefront of advancing cancer treatment options. Their comprehensive approach showcases an unwavering commitment to improving the quality of life for cancer patients around the world.

Community Response and Future Outlook

Community leaders are invigorated by the launch of the Striking Out Cancer campaign. Alex Seyferth, vice president of Cubs Corporate Partnerships, noted, "We are honored to work alongside AbbVie as we focus on taking action against cancer. Every dollar raised will support organizations actively on the front lines of fighting this disease, allowing us to expand our reach and impact." This joint effort represents a powerful alliance between sports and health, fostering a broad coalition dedicated to fighting cancer.

Impact on Cancer Organizations

As the campaign progresses, the funds collected will not only amplify the efforts of local organizations but also promote a vision of a world where cancer can be prevented or, at the very least, cured. Nancy R. Daly, CEO of Conquer Cancer, shared her gratitude, stating, "The assistance from AbbVie and Cubs Charities is essential in helping us fulfill our mission. Together, we aim for a future where every survivor leads a healthy life, free from the burdens of cancer." This collaborative spirit is vital for the ongoing fight against cancer.

Conclusion of the Campaign’s Launch

The Striking Out Cancer campaign kicked off in the late spring and is set to run throughout the regular season of the Cubs, with hopes of making a transformative impact during its inaugural year. This partnership not only underscores the power of community engagement but also the critical role that corporate responsibility can play in advancing public health initiatives.

Frequently Asked Questions

What is the purpose of the 'Striking Out Cancer' campaign?

The campaign aims to raise awareness and funds for cancer advocacy and support non-profit organizations dedicated to fighting cancer.

How will donations be calculated during the season?

For every strikeout by a Chicago Cubs pitcher at home, AbbVie will donate $233, a figure that reflects the number of Americans diagnosed with cancer every hour.

Which organizations will benefit from the donations?

Funds will primarily go to Cubs Charities and organizations like Conquer Cancer®, focusing on cancer research and support.

What is AbbVie’s role in cancer treatment?

AbbVie is dedicated to developing transformative medicines aimed at treating various types of cancers, contributing to advancements in oncology.

How long will the campaign run?

The campaign began in May and will continue throughout the 2025 Chicago Cubs regular season.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading